Ocular Therapeutix
OCUL
OCUL
118 hedge funds and large institutions have $330M invested in Ocular Therapeutix in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
16.26% more ownership
Funds ownership: 50.91% → 67.17% (+16%)
4% more funds holding
Funds holding: 113 → 118 (+5)
23% less call options, than puts
Call options by funds: $1M | Put options by funds: $1.3M
Holders
118
Holding in Top 10
3
Calls
$1M
Puts
$1.3M
Top Buyers
| 1 | +$41.2M | |
| 2 | +$34.7M | |
| 3 | +$20.1M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$17.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$10M |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$1.78M | |
| 3 | -$1.11M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.08M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$958K |